抗血栓-话题@MedSci

#抗血栓#

65篇内容 | 2695人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1574110, encodeId=88ab15e411060, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Eur J Clin Pharmacol：哪些因素影响房颤患者预防卒中的抗血栓治疗决策？, objectType=article, longId=120369, objectId=990812036991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=990812036991, replyNumber=0, likeNumber=89, createdTime=2017-11-18, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=990812036991, moduleTitle=Eur J Clin Pharmacol：哪些因素影响房颤患者预防卒中的抗血栓治疗决策？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=990812036991)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574109, encodeId=7ca915e4109b3, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=NEJM：房颤患者PCI后双抗还是三重抗血栓治疗更好？, objectType=article, longId=119427, objectId=a68511942e0c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a68511942e0c, replyNumber=0, likeNumber=118, createdTime=2017-11-11, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a68511942e0c, moduleTitle=NEJM：房颤患者PCI后双抗还是三重抗血栓治疗更好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a68511942e0c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574108, encodeId=e7e615e410873, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=BMJ：新型抗血栓药DOAC可有效替代华法林，安全性更高！, objectType=article, longId=116673, objectId=b9541166e3e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9541166e3e5, replyNumber=0, likeNumber=108, createdTime=2017-10-20, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9541166e3e5, moduleTitle=BMJ：新型抗血栓药DOAC可有效替代华法林，安全性更高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9541166e3e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574107, encodeId=8c7215e410788, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Sci Trans Med：科学家改进并合成出更有效、更安全的低分子抗血栓药！, objectType=article, longId=112294, objectId=0e771122949f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e771122949f, replyNumber=0, likeNumber=86, createdTime=2017-09-09, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e771122949f, moduleTitle=Sci Trans Med：科学家改进并合成出更有效、更安全的低分子抗血栓药！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e771122949f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574106, encodeId=c33e15e410683, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Mayo Clin Proc：AF患者遵照指南抗血栓好处多多！, objectType=article, longId=111531, objectId=0b53111531d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b53111531d5, replyNumber=0, likeNumber=141, createdTime=2017-09-02, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b53111531d5, moduleTitle=Mayo Clin Proc：AF患者遵照指南抗血栓好处多多！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b53111531d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574105, encodeId=4ae515e410591, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=JACC：经导管主动脉瓣置换术后阿司匹林与阿司匹林加氯吡格雷抗血栓治疗的比较, objectType=article, longId=104556, objectId=28d310455605, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28d310455605, replyNumber=0, likeNumber=30, createdTime=2017-07-06, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28d310455605, moduleTitle=JACC：经导管主动脉瓣置换术后阿司匹林与阿司匹林加氯吡格雷抗血栓治疗的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28d310455605)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574104, encodeId=155915e410430, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！, objectType=article, longId=104445, objectId=f1ee10444578, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1ee10444578, replyNumber=0, likeNumber=68, createdTime=2017-07-05, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1ee10444578, moduleTitle=Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1ee10444578)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574103, encodeId=aeba15e41032d, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Redox Biol：HPW-RX40具有作为新型抗血栓药物的潜力, objectType=article, longId=102683, objectId=88fc102683b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88fc102683b8, replyNumber=0, likeNumber=105, createdTime=2017-06-22, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88fc102683b8, moduleTitle=Redox Biol：HPW-RX40具有作为新型抗血栓药物的潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88fc102683b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574102, encodeId=387215e410226, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=来自蛇毒的新型抗血栓药，效果更好毒性更低！, objectType=article, longId=101393, objectId=690410139388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=690410139388, replyNumber=0, likeNumber=59, createdTime=2017-06-11, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=690410139388, moduleTitle=来自蛇毒的新型抗血栓药，效果更好毒性更低！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=690410139388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574101, encodeId=630915e4101d4, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Nat Commun：抗血栓治疗新突破：新型小分子可成功防血栓，避免异常出血！, objectType=article, longId=100423, objectId=60e5100423cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60e5100423cf, replyNumber=0, likeNumber=59, createdTime=2017-06-03, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60e5100423cf, moduleTitle=Nat Commun：抗血栓治疗新突破：新型小分子可成功防血栓，避免异常出血！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60e5100423cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574100, encodeId=df7c15e41004e, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Adv Mater：智能响应型抗血栓贴片, objectType=article, longId=100041, objectId=80091000410b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80091000410b, replyNumber=0, likeNumber=73, createdTime=2017-05-30, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80091000410b, moduleTitle=Adv Mater：智能响应型抗血栓贴片, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80091000410b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574099, encodeId=5c9215e4099dd, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Cochrane DB Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”, objectType=article, longId=97777, objectId=4c9f9e777ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c9f9e777ac, replyNumber=0, likeNumber=53, createdTime=2017-05-04, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c9f9e777ac, moduleTitle=Cochrane DB Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c9f9e777ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574098, encodeId=31e915e40988d, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Cochrane Database Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”, objectType=article, longId=97760, objectId=2dd39e7608b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dd39e7608b, replyNumber=0, likeNumber=62, createdTime=2017-05-04, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dd39e7608b, moduleTitle=Cochrane Database Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dd39e7608b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574097, encodeId=196415e409716, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=JAMA：硬膜下血肿的发生率与抗血栓形成药物的使用有关, objectType=article, longId=90275, objectId=148c902e575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=148c902e575, replyNumber=0, likeNumber=31, createdTime=2017-03-03, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=148c902e575, moduleTitle=JAMA：硬膜下血肿的发生率与抗血栓形成药物的使用有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=148c902e575)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574096, encodeId=6d3215e409607, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Neurology：抗血栓预处理提高原发性脑出血极早期死亡率, objectType=article, longId=88663, objectId=0a0a8866374, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a0a8866374, replyNumber=0, likeNumber=64, createdTime=2017-02-14, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a0a8866374, moduleTitle=Neurology：抗血栓预处理提高原发性脑出血极早期死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a0a8866374)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574095, encodeId=8c5a15e409575, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=2015EHRA立场文件——接受心脏电生理手术患者的抗血栓治疗发布, objectType=article, longId=78469, objectId=aa4fe846957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa4fe846957, replyNumber=0, likeNumber=31, createdTime=2016-09-27, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa4fe846957, moduleTitle=2015EHRA立场文件——接受心脏电生理手术患者的抗血栓治疗发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa4fe846957)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574094, encodeId=8dad15e4094a0, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Stroke：有卒中危险因素的人群行抗血栓治疗，可改善卒中后预后, objectType=article, longId=73767, objectId=70ffe3767c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70ffe3767c9, replyNumber=0, likeNumber=63, createdTime=2016-07-27, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70ffe3767c9, moduleTitle=Stroke：有卒中危险因素的人群行抗血栓治疗，可改善卒中后预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70ffe3767c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574093, encodeId=d11c15e409364, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=BMJ：抗血栓和抗出血该如何平衡？, objectType=article, longId=58937, objectId=0f5d5893eee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f5d5893eee, replyNumber=0, likeNumber=61, createdTime=2015-11-19, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f5d5893eee, moduleTitle=BMJ：抗血栓和抗出血该如何平衡？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f5d5893eee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574092, encodeId=f93115e4092fa, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=吃抗血栓药，你的基因“配合”吗？, objectType=article, longId=52684, objectId=d13f526846e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d13f526846e, replyNumber=0, likeNumber=64, createdTime=2015-07-02, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d13f526846e, moduleTitle=吃抗血栓药，你的基因“配合”吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d13f526846e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1574091, encodeId=075e15e4091db, content=<a href='/topic/show?id=ee4955e5730' target=_blank style='color:#2F92EE;'>#抗血栓#</a>, objectTitle=Stroke：心房纤颤患者急性脑缺血性卒中后的抗血栓治疗, objectType=article, longId=42389, objectId=abf4423898b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abf4423898b, replyNumber=0, likeNumber=71, createdTime=2014-11-12, rootId=0, userName=gwc388, userId=a26516008049, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abf4423898b, moduleTitle=Stroke：心房纤颤患者急性脑缺血性卒中后的抗血栓治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abf4423898b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗血栓

2020-05-29

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

Eur J Clin Pharmacol：哪些因素影响房颤患者预防卒中的抗血栓治疗决策？

2017-11-18

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

NEJM：房颤患者PCI后双抗还是三重抗血栓治疗更好？

2017-11-11

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

BMJ：新型抗血栓药DOAC可有效替代华法林，安全性更高！

2017-10-20

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

Sci Trans Med：科学家改进并合成出更有效、更安全的低分子抗血栓药！

2017-09-09

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

Mayo Clin Proc：AF患者遵照指南抗血栓好处多多！

2017-09-02

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

JACC：经导管主动脉瓣置换术后阿司匹林与阿司匹林加氯吡格雷抗血栓治疗的比较

2017-07-06

智慧医人 (审核中...)

前往app查看评论内容

#抗血栓#

Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！

2017-07-05

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

Redox Biol：HPW-RX40具有作为新型抗血栓药物的潜力

2017-06-22

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

来自蛇毒的新型抗血栓药，效果更好毒性更低！

2017-06-11

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

Nat Commun：抗血栓治疗新突破：新型小分子可成功防血栓，避免异常出血！

2017-06-03

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

Adv Mater：智能响应型抗血栓贴片

2017-05-30

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

Cochrane DB Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”

2017-05-04

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

Cochrane Database Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”

2017-05-04

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

JAMA：硬膜下血肿的发生率与抗血栓形成药物的使用有关

2017-03-03

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

Neurology：抗血栓预处理提高原发性脑出血极早期死亡率

2017-02-14

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

2015EHRA立场文件——接受心脏电生理手术患者的抗血栓治疗发布

2016-09-27

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

Stroke：有卒中危险因素的人群行抗血栓治疗，可改善卒中后预后

2016-07-27

hb2008ye (审核中...)

前往app查看评论内容

#抗血栓#

BMJ：抗血栓和抗出血该如何平衡？

2015-11-19

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

吃抗血栓药，你的基因“配合”吗？

2015-07-02

gwc388 (审核中...)

前往app查看评论内容

#抗血栓#

Stroke：心房纤颤患者急性脑缺血性卒中后的抗血栓治疗

2014-11-12

科室
- - 订阅+
  - 更多科室
工具
服务